BeOne Medicines

688235

249.241.75% ( -4.45 )

Delay Closed: Oct 30, 15:00:00

Q2 2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: BeOne Medicines(688235) the Revenue is 11.58 B (+22.87%), Beat estimate;the EBIT is 2.207 B (+250.6%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueExceed expectations

11.58B22.87%

10.99B16.65%

+0.59B6.22%

EBITExceed expectations

2.21B250.56%

1.55B146.90%

+0.65B103.66%

Upcoming earnings report - FY2026 Q3 Earning Release

Available dateNov 5, 2026

Estimate Revenue11.73 B

Estimate EBIT--

Estimate EPS--

Revenue

ActualEstimateUnit: CNY

Quarterly

EBIT

ActualEstimateUnit: CNY

Quarterly

Net income

ActualEstimateUnit: CNY

Quarterly

EPS

ActualEstimateUnit: CNY

Quarterly